相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Loss of Function of GALNT2 Lowers High-Density Lipoproteins in Humans, Nonhuman Primates, and Rodents
Sumeet A. Khetarpal et al.
CELL METABOLISM (2016)
The PGE2 EP3 Receptor Regulates Diet-Induced Adiposity in Male Mice
Ryan P. Ceddia et al.
ENDOCRINOLOGY (2016)
Farnesoid X receptor activation increases reverse cholesterol transport by modulating bile acid composition and cholesterol absorption in mice
Yang Xu et al.
HEPATOLOGY (2016)
EP3 receptor deficiency attenuates pulmonary hypertension through suppression of Rho/TGF-β1 signaling
Ankang Lu et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
The receptor EP3 to PGE2: A rational target to prevent atherothrombosis without inducing bleeding
Marie-Anne Mawhin et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2015)
PAQR3 modulates cholesterol homeostasis by anchoring Scap/SREBP complex to the Golgi apparatus
Daqian Xu et al.
NATURE COMMUNICATIONS (2015)
Cholesterol, inflammation and innate immunity
Alan R. Tall et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Blocking the EP3 receptor for PGE2 with DG-041 decreases thrombosis without impairing haemostatic competence
Peggy Tilly et al.
CARDIOVASCULAR RESEARCH (2014)
The Arachidonic Acid Metabolome Serves as a Conserved Regulator of Cholesterol Metabolism
Egon Demetz et al.
CELL METABOLISM (2014)
Cytoplasmic Tyrosine Phosphatase Shp2 Coordinates Hepatic Regulation of Bile Acid and FGF15/19 Signaling to Repress Bile Acid Synthesis
Shuangwei Li et al.
CELL METABOLISM (2014)
I Prostanoid Receptor-Mediated Inflammatory Pathway Promotes Hepatic Gluconeogenesis Through Activation of PKA and Inhibition of AKT
Shuai Yan et al.
DIABETES (2014)
Cyclooxygenase-2-Derived Prostaglandin E2 Promotes Injury-Induced Vascular Neointimal Hyperplasia Through the E-prostanoid 3 Receptor
Jian Zhang et al.
CIRCULATION RESEARCH (2013)
Celecoxib, a selective cyclooxygenase-2 inhibitor, lowers plasma cholesterol and attenuates hepatic lipid peroxidation during carbon-tetrachloride-associated hepatotoxicity in rats
Martins Ekor et al.
DRUG AND CHEMICAL TOXICOLOGY (2013)
Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice
Bo Kong et al.
HEPATOLOGY (2012)
Disruption of the 5-lipoxygenase pathway attenuates atherogenesis consequent to COX-2 deletion in mice
Zhou Yu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Prostaglandins and Inflammation
Emanuela Ricciotti et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Liver Receptor Homolog-1 Is Critical for Adequate Up-regulation of Cyp7a1 Gene Transcription and Bile Salt Synthesis During Bile Salt Sequestration
Carolien Out et al.
HEPATOLOGY (2011)
Inflammatory stress exacerbates hepatic cholesterol accumulation via increasing cholesterol uptake and de novo synthesis
Lei Zhao et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Emotion Recollected in Tranquility: Lessons Learned from the COX-2 Saga
Tilo Grosser et al.
ANNUAL REVIEW OF MEDICINE (2010)
The acute phase response inhibits reverse cholesterol transport
Kenneth R. Feingold et al.
JOURNAL OF LIPID RESEARCH (2010)
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Peter Duewell et al.
NATURE (2010)
Prostaglandin E2 Via Steroidogenic Factor-1 Coordinately Regulates Transcription of Steroidogenic Genes Necessary for Estrogen Synthesis in Endometriosis
Erkut Attar et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Prostaglandin F2α elevates blood pressure and promotes atherosclerosis
Ying Yu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Increased Inflammatory Gene Expression in ABC Transporter-Deficient Macrophages Free Cholesterol Accumulation, Increased Signaling via Toll-Like Receptors, and Neutrophil Infiltration of Atherosclerotic Lesions
Laurent Yvan-Charvet et al.
CIRCULATION (2008)
Cellular cholesterol trafficking and compartmentalization
Elina Ikonen
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Mouse models for atherosclerosis and pharmaceutical modifiers
Susanne Zadelaar et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
A novel anti-atherogenic role for COX-2-potential mechanism for the cardiovascular side effects of COX-2 inhibitors
Ajay Narasimha et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2007)
Night eating and obesity in the EPH-deficient mouse
Manuel Sanchez-Alavez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Vascular wall-produced prostaglandin E2 exacerbates arterial thrombosis and atherothrombosis through platelet EP3 receptors
Sabrina Gross et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
EP3 prostaglandin receptors in the median preoptic nucleus are critical for fever responses
Michael Lazarus et al.
NATURE NEUROSCIENCE (2007)
Overexpression of COX-2, Prostaglandin E Synthase-1 and Prostaglandin E Receptors in blood mononuclear cells and plaque of patients with carotid atherosclerosis:: Regulation by nuclear factor-κB
Almudena Gomez-Hernandez et al.
ATHEROSCLEROSIS (2006)
Bile acids and cytokines inhibit the human cholesterol 7α-hydroxylase gene via the JNK/c-Jun pathway in human liver cells
Tiangang Li et al.
HEPATOLOGY (2006)
The 2-series prostaglandins suppress VLDL secretion in an inflammatory condition-dependent manner in primary rat hepatocytes
S Pérez et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2006)
Glucagon and cAMP inhibit cholesterol 7 alpha-hydroxylase (CYP7A1) gene expression in human hepatocytes: Discordant regulation of bile acid synthesis and gluconeogenesis
KH Song et al.
HEPATOLOGY (2006)
Regulation of bile acid biosynthesis by hepatocyte nuclear factor 4 alpha
Y Inoue et al.
JOURNAL OF LIPID RESEARCH (2006)
Mechanism of rifampicin and pregnane X receptor inhibition of human cholesterol 7 alpha-hydroxylase gene transcription
TG Li et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2005)
The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: Peptoid molecular transporters
PA Wender et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
